ABSTRACT
We investigate the application of Shouwu Yizhi prescription (SYP) in decubation of patients with ischemic stroke (IS). The clinical data of 106 patients recovering from IS who came to our hospital from December 2019 to December 2020 were selected for retrospective analysis, and they were separated into experimental group (n = 53, basic treatment + SYP) and control group (n = 53, basic treatment) based on the principle of random grouping. The clinical indexes such as lipid indexes and neurological disability score (NDS) after treatment were compared between both groups to comprehensively evaluate the clinical effects of different treatment regimens. Except for high-density lipoprotein cholesterol value, the lipid indexes in the experimental group after treatment were remarkably lower than those in the control group (P < 0.001). After treatment, the levels of hypersensitive C-reactive protein, homocysteine and lipoprotein-associated phospholipase A2 were remarkably lower in the experimental group than control group (P < 0.05). After treatment, the experimental group had remarkably higher mean scores of Montreal Cognitive Assessment, Fugl-Meyer Assessment in upper and lower limbs and lower NDS than control group (P < 0.001). SYP is an efficient treatment plan in decubation of IS, which can effectively improve the blood lipid indexes and neurological function of patients, and further studies will help establish a better solution for such patients.
Disclosure statement
No potential conflict of interest was reported by the author(s).
Additional information
Funding
Notes on contributors
Chao Chen
Chao Chen, male, M.D. Mainly engaged in clinical research on the integration of traditional Chinese and Western medicine. Research direction: Integrated traditional Chinese and Western medicine for the treatment of cerebrovascular diseases and geriatric internal medicine diseases.
Guangqing Cheng
Guangqing Cheng, male, Master, Engaged in clinical work of traditional Chinese medicine for 25 years, proficient in the diagnosis and treatment of cardiovascular and cerebrovascular diseases, geriatric diseases, spleen, stomach, liver and gallbladder diseases, and exogenous diseases in traditional Chinese medicine. Research direction: prevention and treatment of atherosclerotic plaque formation with traditional Chinese and western medicine, diagnosis and treatment of vertigo.
Ruiqi Jia
Ruiqi Jia, female, Master of medicine, The Traditional Chinese Medicine Department of Shandong Provincial Police Officer General Hospital, Mainly engages in clinical research on the integration of traditional Chinese and Western medicine. Research direction: The treatment of cerebrovascular diseases and internal medicine diseases through the integration of traditional Chinese and Western medicine.
Aishuai Wang
Aishuai Wang, male, M.D. Traditional Chinese Medicine Internal Medicine (Diagnosis and Treatment of Lung Cancer with Integrated Traditional Chinese and Western Medicine).
Anrong Wang
Anrong Wang, female, M.D. Research direction: Diagnosis and treatment of nervous system disease with integrated traditional Chinese and western medicine.
Xiaoni Yang
Xiaoni Yang, female, M.D. Mainly engaged in clinical research on the integration of traditional Chinese and Western medicine. Research direction: Treatment of Cardiovascular and Cerebrovascular Diseases and Elderly Internal Medicine Diseases through the Combination of Traditional Chinese and Western Medicine.